AbbVie Inc.

AbbVie Inc.verified

ABBV

Price:

$179.8

Market Cap:

$317.73B

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pan...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2013-01-02

Stock Exchange

NYSE

Ticker

ABBV

The ROE as of December 2024 (TTM) for AbbVie Inc. (ABBV) is 65.72%

According to AbbVie Inc.’s latest financial reports and current stock price. The company's current ROE is 65.72%. This represents a change of 269.59% compared to the average of 17.78% of the last 4 quarters.

AbbVie Inc. (ABBV) Historical ROE (quarterly & annually)

How has ABBV ROE performed in the past?

The mean historical ROE of AbbVie Inc. over the last ten years is 52.68%. The current 65.72% ROE has changed 24.75% with respect to the historical average. Over the past ten years (40 quarters), ABBV's ROE was at its highest in in the March 2018 quarter at 78.33%. The ROE was at its lowest in in the September 2018 quarter at -94.04%.

Quarterly (TTM)
Annual

Average

52.68%

Median

71.75%

Minimum

-96.45%

Maximum

130.39%

AbbVie Inc. (ABBV) ROE by Quarter and Year

Discovering the peaks and valleys of AbbVie Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 112.20%

Maximum Annual ROE = 130.39%

Minimum Annual Increase = -164.64%

Minimum Annual ROE = -96.45%

Quarterly (TTM)
Annual
YearROEChange
202346.94%-31.57%
202268.60%-8.42%
202174.91%112.20%
202035.30%-136.60%
2019-96.45%43.24%
2018-67.33%-164.64%
2017104.16%-18.88%
2016128.41%-1.52%
2015130.39%28.04%
2014101.84%10.82%

AbbVie Inc. (ABBV) Average ROE

How has ABBV ROE performed in the past?

The current ROE of AbbVie Inc. (ABBV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

63.48%

5-year avg

25.86%

10-year avg

52.68%

AbbVie Inc. (ABBV) ROE vs. Peers

How is ABBV’s ROE compared to its peers?

AbbVie Inc.’s ROE is less than Merck & Co., Inc. (29.27%), less than Pfizer Inc. (4.72%), less than Eli Lilly and Company (65.15%), greater than Bristol-Myers Squibb Company (-36.26%), less than Johnson & Johnson (20.94%), less than Amgen Inc. (68.49%), greater than Gilead Sciences, Inc. (0.65%),

CompanyROEMarket cap
29.27%$251.57B
4.72%$151.34B
65.15%$755.34B
-36.26%$117.15B
20.94%$351.15B
68.49%$142.17B
0.65%$117.09B

Build a custom stock screener for AbbVie Inc. (ABBV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbbVie Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AbbVie Inc. (ABBV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AbbVie Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is AbbVie Inc.'s ROE?

How is the ROE calculated for AbbVie Inc. (ABBV)?

What is the highest ROE for AbbVie Inc. (ABBV)?

What is the 3-year average ROE for AbbVie Inc. (ABBV)?

What is the 5-year average ROE for AbbVie Inc. (ABBV)?

How does the current ROE for AbbVie Inc. (ABBV) compare to its historical average?